The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.
4don MSN
A new Medicare program that uses AI for prior authorizations is hurting patients and delaying care
Six states are part of a pilot program by CMS to reduce “waste, fraud and abuse.” ...
Proponents of medicinal hemp and medical marijuana are generally pleased with the pilot program launched in April by CMS to ...
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...
The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...
In a first, the federal government is allowing certain hemp products to be used as treatments for people on Medicare. The new program, called the Substance Access Beneficiary Engagement Incentive, is ...
April 29 (Reuters) - The U.S. Centers for Medicare & Medicaid Services said on Wednesday it has extended key application ...
The Trump administration decided to put the pilot on hold until at least 2027.
The Legislative Budget Commission on Tuesday approved two requests from the Agency for Health Care Administration to give it ...
The Trump administration will require all 50 states to explain their plans to revalidate some of their Medicaid providers in ...
But in early March, Edgerly discovered that he’d been denied the procedure, despite it being covered by his traditional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results